Logo CICANCER
Intranet Colaborate

Old CIC Events

Spatial synthetic lethality- a new approach to treat B cell lymphoma (?) 03/02/2023

Spatial synthetic lethality- a new approach to treat B cell lymphoma (?)

Ingo Ringshausen — University of Cambridge, Wellcome–MRC Cambridge Stem Cell Institute

Self-organization of MAPK Signaling Dynamics in the Epithelium 02/02/2023

Self-organization of MAPK Signaling Dynamics in the Epithelium

Olivier Pertz — Institute of Cell Biology, University of Bern (Swizerland)

Cell-of-origin as a route to understand the onset of aggressive prostate tumours 01/02/2023

Cell-of-origin as a route to understand the onset of aggressive prostate tumours

Esther Baena — Cancer Research UK Manchester Institute, University of Manchester

Defensa de tesis doctoral: Guanosine-7 tRNA methylation regulates Prostate Cancer progression through protein reprogramming via tRNA-derived fragments biogenesis 27/01/2023

Defensa de tesis doctoral: Guanosine-7 tRNA methylation regulates Prostate Cancer progression through protein reprogramming via tRNA-derived fragments biogenesis

Raquel García-Vílchez — Programa de doctorado Biociencias: Biología y Clínica del Cáncer y Medicina Traslacional

VAV1 mutations act as cancer drivers in T cell lymphomas 26/01/2023

VAV1 mutations act as cancer drivers in T cell lymphomas

Javier Robles Valero — Centro de Investigación del Cáncer (CIC-IBMCC), Salamanca.

Unexpected noncoding RNA roles in the regulation of the cancer genome 19/01/2023

Unexpected noncoding RNA roles in the regulation of the cancer genome

Maite Huarte — CIMA, University of Navarra

A new approach to old problems: epitranscriptomics in aging and rejuvenation 12/01/2023

A new approach to old problems: epitranscriptomics in aging and rejuvenation

Diana Guallar — Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela

Emerging biomarkers for precision cancer medicine: Discovery, validation and clinical application 15/12/2022

Emerging biomarkers for precision cancer medicine: Discovery, validation and clinical application

Dr. Jian-Hua Mao — Lawrence Berkeley National Laboratory / University of California [Berkeley, USA]

Symposium on: Cancer genomics and epitranscriptomics: from the bench to the clinic 30/11/2022

Symposium on: Cancer genomics and epitranscriptomics: from the bench to the clinic

Tony Kouzarydes, Christina Curtis, Chuan He, Núria López-Bigas, Manel Esteller, Michaela Frye, Mathieu Lupien, Vessela Kristensen, Kamil R Kranc Barts, Cristian Bellodi, Donate Weghorn, Marco Gerlinger, Direna Alonso Curbelo, Óscar Rueda, Zohar Yakhini, José Seoane — https://symposiumcic2022.usal.es/

Defensa de la tesis doctoral "VRK1 functions in the DNA damage and oxidative stress responses and its implication in novel cancer therapies" 25/11/2022

Defensa de la tesis doctoral "VRK1 functions in the DNA damage and oxidative stress responses and its implication in novel cancer therapies"

Elena Navarro Carrasco — Programa de doctorado Biociencias: Biología y Clínica del Cáncer y Medicina Traslacional

Hyaluronic acid is a master regulator of tumor stroma 24/11/2022

Hyaluronic acid is a master regulator of tumor stroma

Juan Rodríguez Vita — Centro de Investigación Príncipe Felipe, Valencia [Spain]

Diversity of Quaternary Structures Regulates Nuclear Receptor Activities in Health and Disease 17/11/2022

Diversity of Quaternary Structures Regulates Nuclear Receptor Activities in Health and Disease

Eva Estébanez-Perpiñá — Institute of Biomedicine of the University of Barcelona (IBUB)